DONNELL HAMMONS: Open Payments
NPI 1548221005 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,599 in 81 payments from 22 companies in 2025. Trend: 2023 $2,083 · 2024 $1,921 · 2025 $1,599
Food & beverage: $1,599
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $277 |
| ABBVIE INC. | 10 | $200 |
| Lilly USA, LLC | 12 | $183 |
| PFIZER INC. | 12 | $179 |
| Novo Nordisk Inc | 10 | $162 |
| SHIELD THERAPEUTICS INC | 3 | $113 |
| Amgen Inc. | 5 | $90 |
| Exact Sciences Corporation | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
Products named: AIRSUPRA, MOUNJARO, ACCRUFER, FARXIGA, QULIPTA, VRAYLAR, PREVNAR 20, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
